Orphan Drug Program / Therapeutic Goods Administration.
Orphan Drug Program / Therapeutic Goods Administration.
About this item
Full title
Author / Creator
Publisher
Woden, A.C.T. : The Administration, 1998.
Date
1998.
Call Numbers
N353.9980994/1
Record Identifier
MMS ID
Language
English
Formats
Physical Description
Physical content
15 p. ; 26 cm.
Contents
Introduction -- The Australian Orphan Drug Program -- 1. Criteria for orphan drug designation -- 2. Orphan drug designation -- 3. Process for orphan drug designation and registration -- 4. Fees and charges -- 5. Marketing and postmarketing -- 6. Consultation with the TGA about special cases -- 7. Co...
Publication information
Publisher
Woden, A.C.T. : The Administration, 1998.
Place of Publication
Australian Capital Territory
Date Published
1998.
Access and use
Access Conditions
Commonwealth of Australia 1998.
Subjects
More information
Scope and Contents
Summary
Orphan drug products are drugs, vaccines or in vivo diagnostic agents which physicians use to treat, prevent or diagnose rare diseases. Usually the drugs are not commercially viable. Pharmaceutical companies often do not develop and market such products because the financial return is small compared wtih the costs of development and marketing. The...
Alternative Titles
Full title
Orphan Drug Program / Therapeutic Goods Administration.
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Call Numbers
N353.9980994/1
Record Identifier
74VMjLxkvp0d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/74VMjLxkvp0d
Other Identifiers
ISBN
0642272980
9780642272980
DDC
353.9980994
MMS ID
991001124789702626
